Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
GB SCIENCES INCGB Sciences Reports Revenue Growth to $97,235 Amid Ongoing Losses and Cost Reductions
Journey Medical CorpJourney Medical Corporation Reports Q2 2025 Financial Results with Revenue Increase and Reduced Net Losses
Fifth District Bancorp, Inc.Fifth District Bancorp Reports 357.7% Increase in Net Income for Q2 2025
Armata Pharmaceuticals, Inc.Armata Pharmaceuticals Reports $16.3 Million Net Loss in Q2 2025
Hyliion Holdings Corp.Hyliion Reports $1.5 Million Revenue in Q2 2025, Net Loss Increases to $13.4 Million
CarParts.com, Inc.CarParts.com Reports 5.3% Sales Increase but Wider Net Loss in Q2 2025
AI Financial CorpALT5 Sigma Corporation Reports Revenue Growth to $6.4 Million in Latest 10-Q Filing
TherapeuticsMD, Inc.TherapeuticsMD Reports Revenue Growth and Improved Losses in Q2 2025
TEAM INCTeam, Inc. Reports 8.5% Revenue Growth but Incurred $4.3 Million Net Loss in Q2 2025
STRATUS PROPERTIES INCStratus Properties Reports $11.6 Million Revenue in Q2 2025, Net Income Turnaround
INFINITY NATURAL RESOURCES, INC.Infinity Natural Resources Reports $74.5 Million Revenue in Q2 2025, Driven by Natural Gas Sales
Annovis Bio, Inc.Annovis Bio Reports $6.2 Million Net Loss in Q2 2025, Increases Total Assets to $21.5 Million
Citius Pharmaceuticals, Inc.Citius Pharmaceuticals Reports Q3 2025 Financial Results with $9.2 Million Net Loss
Affinity Bancshares, Inc.Affinity Bancshares Reports Increased Net Income and Asset Growth in Q2 2025
Stran & Company, Inc.Stran & Company Reports 95.2% Revenue Growth to $32.6 Million in Q2 2025
Spero Therapeutics, Inc.Spero Therapeutics Reports 38.9% Revenue Growth and Improved Net Loss in Q2 2025
GD Culture Group LtdGD Culture Group Reports Significant Asset Growth and Reduced Net Losses in Q2 2025
Central Plains Bancshares, Inc.Central Plains Bancshares Reports Increased Net Income and Earnings Per Share for Q2 2025
BioRestorative Therapies, Inc.BioRestorative Therapies Reports Revenue Growth but Significant Net Loss in Latest 10-Q Filing
Microbot Medical Inc.Microbot Medical Reports Increased Net Loss and Significant Asset Growth in Latest 10-Q Filing
Moleculin Biotech, Inc.Moleculin Biotech Reports $7.6 Million Net Loss in Q2 2025, Seeks Additional Funding
CITIUS ONCOLOGY, INC.Citius Oncology Reports Increased Net Loss and Prepares for LYMPHIR Launch
PRECIGEN, INC.Precigen Reports 19.4% Revenue Growth in Q2 2025, Despite $26.6M Net Loss
Kodiak AI, Inc.Ares Acquisition Corporation II Reports Significant Decline in Net Income for Q2 2025
IRIDEX CORPIRIDEX Reports 7.4% Revenue Growth in Q2 2025, Net Loss Improves